Concepedia
Statistics
Publications
6
Citations
586
H-Index
Active since
2020
Affiliations
The Netherlands Cancer Institute(Current)
Oncode Institute
University of Regensburg
Delft University of Technology
University of Zurich
Alberto Gil-Jimenez is an author at The Netherlands Cancer Institute specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2020–2024
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa et al. · Nature Medicine · 2020 · 397 citations · Full text
Medicine, Oncology, Urology +11
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial
Hielke M. de Vries, Tynisha S. Rafael, Alberto Gil-Jimenez et al. · Journal of Clinical Oncology · 2023 · 69 citations
Medicine, Oncology, Pharmacotherapy +17
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras‐Sanz et al. · European Urology · 2022 · 46 citations · Full text
Medicine, Oncology, Urology +15
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer
Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa et al. · Frontiers in Immunology · 2021 · 40 citations · Full text
Life Sciences, Immunology, Oncology +17
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors
Alberto Gil-Jimenez, Nick van Dijk, Joris L. Vos et al. · Nature Communications · 2024 · 21 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 6